Engineers Gate Manager LP acquired a new stake in shares of MEDNAX Inc (NYSE:MD) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 17,159 shares of the company’s stock, valued at approximately $955,000.
A number of other large investors have also bought and sold shares of the stock. GHP Investment Advisors Inc. boosted its stake in MEDNAX by 13.8% during the fourth quarter. GHP Investment Advisors Inc. now owns 7,735 shares of the company’s stock valued at $413,000 after buying an additional 940 shares during the period. Amalgamated Bank lifted its stake in MEDNAX by 5.9% during the fourth quarter. Amalgamated Bank now owns 18,448 shares of the company’s stock worth $986,000 after purchasing an additional 1,035 shares during the last quarter. Macquarie Group Ltd. lifted its stake in MEDNAX by 36.1% during the fourth quarter. Macquarie Group Ltd. now owns 4,900 shares of the company’s stock worth $262,000 after purchasing an additional 1,300 shares during the last quarter. Commerce Bank lifted its stake in MEDNAX by 9.6% during the fourth quarter. Commerce Bank now owns 15,868 shares of the company’s stock worth $848,000 after purchasing an additional 1,393 shares during the last quarter. Finally, William Blair Investment Management LLC lifted its stake in MEDNAX by 12.5% during the fourth quarter. William Blair Investment Management LLC now owns 12,749 shares of the company’s stock worth $681,000 after purchasing an additional 1,421 shares during the last quarter. 97.14% of the stock is owned by institutional investors.
In related news, insider John C. Pepia sold 3,000 shares of the business’s stock in a transaction dated Tuesday, March 13th. The stock was sold at an average price of $58.35, for a total transaction of $175,050.00. Following the transaction, the insider now owns 39,716 shares in the company, valued at approximately $2,317,428.60. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 2.70% of the company’s stock.
Several brokerages have issued reports on MD. TheStreet raised MEDNAX from a “c+” rating to a “b” rating in a research note on Monday, March 12th. Jefferies Group set a $58.00 price target on MEDNAX and gave the stock a “hold” rating in a research note on Thursday, March 15th. Zacks Investment Research lowered MEDNAX from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 21st. Credit Suisse Group began coverage on MEDNAX in a research note on Tuesday, March 27th. They set a “neutral” rating and a $57.00 price target for the company. Finally, Robert W. Baird lifted their price target on MEDNAX from $48.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, February 9th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. MEDNAX has an average rating of “Hold” and a consensus price target of $55.92.
MEDNAX opened at $46.64 on Tuesday, according to Marketbeat. MEDNAX Inc has a 1-year low of $40.56 and a 1-year high of $63.04. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.74 and a quick ratio of 1.74. The stock has a market capitalization of $4.44 billion, a PE ratio of 14.81, a P/E/G ratio of 1.19 and a beta of 0.26.
MEDNAX (NYSE:MD) last released its earnings results on Monday, April 30th. The company reported $0.89 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.07. MEDNAX had a return on equity of 10.13% and a net margin of 9.34%. The company had revenue of $901.90 million during the quarter, compared to analyst estimates of $903.75 million. During the same quarter in the previous year, the company posted $0.75 EPS. MEDNAX’s revenue for the quarter was up 7.9% on a year-over-year basis. equities research analysts forecast that MEDNAX Inc will post 3.95 earnings per share for the current year.
MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology, pediatric cardiology, and other pediatric subspecialties physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services.
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.